Evidence map›Paper›PMID 41427174›Full record

ArticleACS omega2025

Study on the Adsorption Behavior of Preservatives in Multidose Eye Drops and Their Interaction with Packaging Materials.

Haoyue Guan, Xiaoxu Han, Jingwen Sun, Jing Wang, Baoming Ning, Huimin Sun, Xia Zhao

Abstract read
In one paragraph

Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Haoyue GuanNational Institute for Food and Drug Control, Beijing 100050, China.ORCID https://orcid.org/0009-0001-9009-6485
Xiaoxu HanNational Institute for Food and Drug Control, Beijing 100050, China.
Jingwen SunNational Institute for Food and Drug Control, Beijing 100050, China.
Jing WangNational Institute for Food and Drug Control, Beijing 100050, China.
Baoming NingNational Institute for Food and Drug Control, Beijing 100050, China.
Huimin SunNational Institute for Food and Drug Control, Beijing 100050, China.
Xia ZhaoNational Institute for Food and Drug Control, Beijing 100050, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With the increasing prevalence of dry eye syndrome and an aging population, multidose eye drops have become predominant in the market due to their convenience. However, the stability of the antimicrobial efficacy is crucial for patient safety, with the interaction between preservatives and packaging materials being particularly significant. This study systematically examined the effects of packaging material type, pH value, preservative type, and formulation components on the adsorption behavior using single-factor experiments, orthogonal design, X-ray photoelectron spectroscopy (XPS) analysis, and quantum mechanical calculations. The research showed that chlorobutanol exhibited the most significant adsorption (12.5% originates from single-factor analysis), and the degree of adsorption was closely related to the solution environment and the surface chemical properties of the materials. Orthogonal experiments indicated that the type of packaging material and the type of active pharmaceutical ingredient were the primary factors influencing preservative adsorption; the type of pH-adjusting agent had no significant effect on preservative adsorption; however, the solution pH acted synergistically with the preservative to influence its adsorption. XPS analysis revealed a synergistic effect between physical and chemical adsorption, while quantum mechanical calculations further demonstrated that the HOMO energy value (with more negative values indicating stronger adsorption) played a key role in determining the adsorption strength. This study provides a scientific basis for the formulation design and packaging material selection of eye drops, helping to enhance product safety and efficacy.

Identifiers

PMID41427174
PMCPMC12713501

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.